Patients’ vaccination status and biologic or DMARD treatment. Values are n (%) unless otherwise specified.
| Characteristics | Values |
|---|---|
| Patients with a history of vaccination with PPSV23 | 88 (67.7) |
| Time since vaccination, mos, mean (range) | 45 (0–180) |
| Biologic treatment | |
| Infliximab | 59 (45.4) |
| Etanercept | 21 (16.2) |
| Adalimumab | 16 (12.3) |
| Tocilizumab | 17 (13.1) |
| Duration of biologic treatment, mos, mean (range) | 43.4 (1–192) |
| Methotrexate | 54 (41.5) |
| Steroids | 25 (19.4) |
| Steroid dose, mean (range) | 7.3 (1–20) |
DMARD: disease-modifying antirheumatic drug; PPSV23: pneumococcal polysaccharide vaccine 23.